ArticleCureus2025
A Machine Learning Approach to Differentiate Congenital and Transient Neonatal Hyperammonemia: A 10-Year Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevated blood ammonia concentration, resulting from various hereditary and acquired conditions, can cause severe damage to the central nervous system, leading to increased rates of disability and infant mortality. In newborns, hyperammonemia is etiologically classified into two main categories: congenital, associated with inborn errors of the urea cycle or organic acidemias, and acquired, which arises secondary to other pathological conditions such as severe perinatal hypoxia, renal or hepatic failure, or intrauterine infections. Despite the differing etiologies, the clinical presentation is often non-specific and may include lethargy, hypotonia, feeding difficulties, respiratory distress, and seizures. This non-specificity frequently leads to initial misdiagnosis. Consequently, a thorough understanding of the pathogenesis, clinical features, and differential diagnosis of congenital versus acquired hyperammonemia is critical for pediatricians, neonatologists, and intensive care specialists. Timely initiation of treatment is paramount, as it directly impacts patient survival and long-term neurological outcomes. Our findings underscore the utility of machine learning in the early differential diagnosis of neonatal hyperammonemia, identifying key predictors that can guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.